MiniMed Group Inc. Common Stock vs Schwab US Dividend Equity ETF — how do they compare? MiniMed Group Inc. Common Stock trades at $19.66 (market cap $5.57B), while Schwab US Dividend Equity ETF trades at $33.03 (market cap $110.56B). The key difference: Schwab US Dividend Equity ETF is far larger — about 19.8× MiniMed Group Inc. Common Stock's market cap, and Schwab US Dividend Equity ETF is more actively traded (23,539,168 versus 23,336,073). Which is the better fit depends on your goals — on Pluang, investors hold MiniMed Group Inc. Common Stock for 1 Days and Schwab US Dividend Equity ETF for 62 Days on average.
| MMED | SCHD | |
|---|---|---|
Market Cap | $5.57B | $110.56B |
Volume | 23,336,073 | 23,539,168 |
Sector | Health | Broad Market / Factor |
52-Week High | $23.84 | $35.21 |
52-Week Low | $10.80 | $26.44 |
Typical Hold Time | 1 Days | 62 Days |
Enterprise Value | $5.37B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SCHD trades at $33.04, up 1.19% today, with a bullish technical signal but mixed moving averages. The ETF focuses on high-quality U.S. dividend stocks, though key valuation ratios like P/E and P/B are not provided in the data. Recent news highlights its outperformance versus the S&P 500 in 2026 and a dividend payment scheduled for September 28, 2026.
Outlook is supported by dividend growth and defensive positioning, but risks include interest rate sensitivity and strict selection rules that may exclude high-growth stocks. Analyst sentiment is mixed, with technical indicators suggesting near-term consolidation around key support at $33.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →